Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Romanos Sklavenitis Pistofidis, M.D.

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma9202251691.180 Why?
HMGA1a Protein12021640.770 Why?
Waldenstrom Macroglobulinemia3202110520.540 Why?
Receptors, CXCR4120187260.460 Why?
RNA-Binding Proteins1202118990.410 Why?
Adaptor Proteins, Signal Transducing1202129150.370 Why?
Monoclonal Gammopathy of Undetermined Significance220201770.300 Why?
Gene Expression Regulation, Neoplastic1202184250.250 Why?
Neoplasm Recurrence, Local1202191850.220 Why?
Disease Models, Animal12021180060.210 Why?
Immunologic Factors2202215750.200 Why?
Bone Marrow3202129410.200 Why?
Clinical Trials, Phase II as Topic120226270.180 Why?
Disease Progression52022132560.170 Why?
Receptor, Interferon alpha-beta120181070.160 Why?
Plasma Cells120215920.150 Why?
Sequence Analysis, RNA2202120110.130 Why?
Mice, SCID1202127150.130 Why?
Stromal Cells1202113530.130 Why?
Mutation22019297170.130 Why?
Clone Cells1201816920.120 Why?
Cell Adhesion1202131390.120 Why?
Cell Proliferation22021104720.120 Why?
Tumor Cells, Cultured1202163130.110 Why?
Neoplasms, Experimental1201812740.110 Why?
Tumor Microenvironment2202135640.100 Why?
Chromosome Aberrations1201818110.100 Why?
Antibodies, Viral1202131640.090 Why?
Neoplasms, Second Primary1201810520.090 Why?
Immunoglobulin G1202145540.090 Why?
Survival Rate22021127730.090 Why?
Base Sequence12021127970.090 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201815150.090 Why?
Immune Tolerance1201822570.080 Why?
Cell Movement1202152120.080 Why?
Decision Support Techniques1201919520.080 Why?
High-Throughput Nucleotide Sequencing1202035850.080 Why?
Asymptomatic Diseases220215520.080 Why?
Immunotherapy1202244140.070 Why?
Neoplasm Proteins1201836910.070 Why?
Prognosis32021290100.070 Why?
Apoptosis1202197150.060 Why?
T-Lymphocytes, Regulatory1201829860.060 Why?
Genomics1202056920.060 Why?
Humans1220227420880.060 Why?
Follow-Up Studies32019390040.050 Why?
Immunologic Tests120211030.050 Why?
Hematopoietic Stem Cell Transplantation1201854250.050 Why?
Risk2202296790.040 Why?
Mice32021810450.040 Why?
Models, Immunological120215270.040 Why?
beta 2-Microglobulin120193150.040 Why?
Antibodies, Blocking120182540.040 Why?
Female620213795920.040 Why?
Antibodies, Neoplasm120182860.040 Why?
Immunocompromised Host120218470.030 Why?
Myeloid Differentiation Factor 88120195710.030 Why?
Animals320211685610.030 Why?
Immunoglobulin M1201915380.030 Why?
Risk Factors42022721450.030 Why?
Male520213495380.020 Why?
Transplantation, Homologous1201847710.020 Why?
Disease-Free Survival1201968910.020 Why?
Biopsy1201967560.020 Why?
Combined Modality Therapy1201886210.020 Why?
Boston1201993050.020 Why?
Phenotype12022163310.020 Why?
Aged, 80 and over22020576830.020 Why?
Cell Line12018159940.010 Why?
Predictive Value of Tests12019150560.010 Why?
Mice, Knockout12018145540.010 Why?
Aged320201629440.010 Why?
Middle Aged320202131270.010 Why?
Adult320202137120.010 Why?
Risk Assessment12019233200.010 Why?
Time Factors12019400540.010 Why?
Prospective Studies12021531870.010 Why?
Signal Transduction12018233870.010 Why?
Sklavenitis Pistofidis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.